STOCK TITAN

[Form 4] Health In Tech, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Director Chike Umemezia of Health In Tech received a grant of 128,474 restricted shares of Class A Common Stock on June 23, 2025, at a price of $0.62 per share under the company's Equity Incentive Plan.

The restricted shares have specific vesting conditions:

  • Full vesting after one year of service from December 23, 2024, or
  • Partial vesting at the first shareholders' meeting based on a pro-rata calculation of service time (up to 12 months) from December 23, 2024

The grant represents a direct ownership position and requires continuous service through the vesting date. This equity compensation aligns the director's interests with shareholders and serves as a retention mechanism through the vesting schedule.

Il direttore Chike Umemezia di Health In Tech ha ricevuto una concessione di 128.474 azioni vincolate di Classe A Common Stock il 23 giugno 2025, al prezzo di 0,62 $ per azione nell'ambito del Piano di Incentivi Azionari della società.

Le azioni vincolate prevedono specifiche condizioni di maturazione:

  • Maturazione completa dopo un anno di servizio dal 23 dicembre 2024, oppure
  • Maturazione parziale alla prima assemblea degli azionisti, calcolata su base proporzionale in relazione al tempo di servizio (fino a 12 mesi) dal 23 dicembre 2024

La concessione rappresenta una posizione di proprietà diretta e richiede un servizio continuativo fino alla data di maturazione. Questa forma di compenso azionario allinea gli interessi del direttore con quelli degli azionisti e funge da meccanismo di fidelizzazione tramite il piano di maturazione.

El director Chike Umemezia de Health In Tech recibió una concesión de 128,474 acciones restringidas de Clase A Common Stock el 23 de junio de 2025, a un precio de $0.62 por acción bajo el Plan de Incentivos de Capital de la empresa.

Las acciones restringidas tienen condiciones específicas de adquisición:

  • Adquisición total después de un año de servicio desde el 23 de diciembre de 2024, o
  • Adquisición parcial en la primera junta de accionistas basada en un cálculo prorrateado del tiempo de servicio (hasta 12 meses) desde el 23 de diciembre de 2024

La concesión representa una posición de propiedad directa y requiere servicio continuo hasta la fecha de adquisición. Esta compensación en acciones alinea los intereses del director con los de los accionistas y funciona como un mecanismo de retención mediante el calendario de adquisición.

Health In Tech의 이사 Chike Umemezia는 2025년 6월 23일 회사의 주식 인센티브 계획에 따라 128,474주의 제한 주식을 주당 $0.62에 부여받았습니다.

제한 주식은 다음과 같은 특정 권리 취득 조건이 있습니다:

  • 2024년 12월 23일부터 1년간 근무 후 완전 권리 취득, 또는
  • 2024년 12월 23일부터 최대 12개월 근무 기간을 기준으로 비례 계산하여 첫 주주총회에서 부분 권리 취득

이 부여는 직접적인 소유권을 의미하며 권리 취득일까지 계속 근무해야 합니다. 이 주식 보상은 이사의 이익을 주주와 일치시키고 권리 취득 일정에 따른 유지 방안으로 작용합니다.

Le directeur Chike Umemezia de Health In Tech a reçu une attribution de 128 474 actions restreintes de Classe A Common Stock le 23 juin 2025, au prix de 0,62 $ par action dans le cadre du Plan d'Incitation en Actions de la société.

Les actions restreintes sont soumises à des conditions spécifiques d'acquisition :

  • Acquisition complète après un an de service à compter du 23 décembre 2024, ou
  • Acquisition partielle lors de la première assemblée des actionnaires, basée sur un calcul au prorata du temps de service (jusqu'à 12 mois) à partir du 23 décembre 2024

L'attribution représente une position de propriété directe et nécessite un service continu jusqu'à la date d'acquisition. Cette rémunération en actions aligne les intérêts du directeur avec ceux des actionnaires et sert de mécanisme de rétention via le calendrier d'acquisition.

Der Direktor Chike Umemezia von Health In Tech erhielt am 23. Juni 2025 eine Zuteilung von 128.474 eingeschränkten Aktien der Klasse A Common Stock zu einem Preis von 0,62 $ pro Aktie im Rahmen des Equity Incentive Plans des Unternehmens.

Die eingeschränkten Aktien unterliegen bestimmten Vesting-Bedingungen:

  • Volle Vesting nach einem Jahr Dienstzeit ab dem 23. Dezember 2024, oder
  • Teilweises Vesting bei der ersten Aktionärsversammlung basierend auf einer anteiligen Berechnung der Dienstzeit (bis zu 12 Monate) ab dem 23. Dezember 2024

Die Zuteilung stellt eine direkte Eigentumsposition dar und erfordert eine kontinuierliche Dienstzeit bis zum Vesting-Termin. Diese Aktienvergütung richtet die Interessen des Direktors mit denen der Aktionäre aus und dient als Bindungsinstrument durch den Vesting-Zeitplan.

Positive
  • Director Chike Umemezia received 128,474 restricted shares at $0.62 per share ($79,654 total value), demonstrating alignment of board interests with shareholders through equity-based compensation
Negative
  • None.

Il direttore Chike Umemezia di Health In Tech ha ricevuto una concessione di 128.474 azioni vincolate di Classe A Common Stock il 23 giugno 2025, al prezzo di 0,62 $ per azione nell'ambito del Piano di Incentivi Azionari della società.

Le azioni vincolate prevedono specifiche condizioni di maturazione:

  • Maturazione completa dopo un anno di servizio dal 23 dicembre 2024, oppure
  • Maturazione parziale alla prima assemblea degli azionisti, calcolata su base proporzionale in relazione al tempo di servizio (fino a 12 mesi) dal 23 dicembre 2024

La concessione rappresenta una posizione di proprietà diretta e richiede un servizio continuativo fino alla data di maturazione. Questa forma di compenso azionario allinea gli interessi del direttore con quelli degli azionisti e funge da meccanismo di fidelizzazione tramite il piano di maturazione.

El director Chike Umemezia de Health In Tech recibió una concesión de 128,474 acciones restringidas de Clase A Common Stock el 23 de junio de 2025, a un precio de $0.62 por acción bajo el Plan de Incentivos de Capital de la empresa.

Las acciones restringidas tienen condiciones específicas de adquisición:

  • Adquisición total después de un año de servicio desde el 23 de diciembre de 2024, o
  • Adquisición parcial en la primera junta de accionistas basada en un cálculo prorrateado del tiempo de servicio (hasta 12 meses) desde el 23 de diciembre de 2024

La concesión representa una posición de propiedad directa y requiere servicio continuo hasta la fecha de adquisición. Esta compensación en acciones alinea los intereses del director con los de los accionistas y funciona como un mecanismo de retención mediante el calendario de adquisición.

Health In Tech의 이사 Chike Umemezia는 2025년 6월 23일 회사의 주식 인센티브 계획에 따라 128,474주의 제한 주식을 주당 $0.62에 부여받았습니다.

제한 주식은 다음과 같은 특정 권리 취득 조건이 있습니다:

  • 2024년 12월 23일부터 1년간 근무 후 완전 권리 취득, 또는
  • 2024년 12월 23일부터 최대 12개월 근무 기간을 기준으로 비례 계산하여 첫 주주총회에서 부분 권리 취득

이 부여는 직접적인 소유권을 의미하며 권리 취득일까지 계속 근무해야 합니다. 이 주식 보상은 이사의 이익을 주주와 일치시키고 권리 취득 일정에 따른 유지 방안으로 작용합니다.

Le directeur Chike Umemezia de Health In Tech a reçu une attribution de 128 474 actions restreintes de Classe A Common Stock le 23 juin 2025, au prix de 0,62 $ par action dans le cadre du Plan d'Incitation en Actions de la société.

Les actions restreintes sont soumises à des conditions spécifiques d'acquisition :

  • Acquisition complète après un an de service à compter du 23 décembre 2024, ou
  • Acquisition partielle lors de la première assemblée des actionnaires, basée sur un calcul au prorata du temps de service (jusqu'à 12 mois) à partir du 23 décembre 2024

L'attribution représente une position de propriété directe et nécessite un service continu jusqu'à la date d'acquisition. Cette rémunération en actions aligne les intérêts du directeur avec ceux des actionnaires et sert de mécanisme de rétention via le calendrier d'acquisition.

Der Direktor Chike Umemezia von Health In Tech erhielt am 23. Juni 2025 eine Zuteilung von 128.474 eingeschränkten Aktien der Klasse A Common Stock zu einem Preis von 0,62 $ pro Aktie im Rahmen des Equity Incentive Plans des Unternehmens.

Die eingeschränkten Aktien unterliegen bestimmten Vesting-Bedingungen:

  • Volle Vesting nach einem Jahr Dienstzeit ab dem 23. Dezember 2024, oder
  • Teilweises Vesting bei der ersten Aktionärsversammlung basierend auf einer anteiligen Berechnung der Dienstzeit (bis zu 12 Monate) ab dem 23. Dezember 2024

Die Zuteilung stellt eine direkte Eigentumsposition dar und erfordert eine kontinuierliche Dienstzeit bis zum Vesting-Termin. Diese Aktienvergütung richtet die Interessen des Direktors mit denen der Aktionäre aus und dient als Bindungsinstrument durch den Vesting-Zeitplan.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Umemezia Chike

(Last) (First) (Middle)
701 S. COLORADO AVE, SUITE 1

(Street)
STUART FL 34994

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/23/2025 A 128,474(1) A $0.62 128,474 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on December 23, 2024, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since December 23, 2024 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date.
By Chike Umemezia /s/ Chike Umemezia 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares of HIT stock did Director Chike Umemezia acquire on June 23, 2025?

Director Chike Umemezia acquired 128,474 shares of HIT Class A Common Stock on June 23, 2025 at a price of $0.62 per share as part of a restricted stock grant.

What are the vesting terms for HIT's restricted stock grant to Director Umemezia?

The restricted shares vest either (i) fully after one year of service from December 23, 2024, or (ii) partially at the first shareholders' meeting if not fully vested, with vesting calculated as a ratio of time served since December 23, 2024 (up to 12 months) divided by 12 months, subject to continuous service.

What is the total value of HIT restricted stock granted to Director Umemezia?

Based on the reported price of $0.62 per share and 128,474 shares granted, the total value of the restricted stock grant to Director Umemezia was approximately $79,654.

What position does Chike Umemezia hold at HIT according to the Form 4?

According to the Form 4 filing, Chike Umemezia serves as a Director of Health In Tech, Inc. (HIT), as indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.
Health In Tech, Inc.

NASDAQ:HIT

HIT Rankings

HIT Latest News

HIT Latest SEC Filings

HIT Stock Data

36.20M
11.63M
71.71%
0.03%
0.22%
Software - Application
Insurance Agents, Brokers & Service
Link
United States
STUART